Siegel R M, Schubert C J, Myers P A, Shapiro R A
Division of General Pediatrics, Children's Hospital Medical Center, Cincinnati, OH, USA.
Pediatrics. 1995 Dec;96(6):1090-4.
To determine the prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, syphilis, and human immunodeficiency virus (HIV) infection in sexually abused children and to develop selective criteria for sexually transmitted disease (STD) testing in these children in our community.
Prospective.
University-affiliated children's hospital in Ohio.
All children evaluated at our hospital for sexual abuse were eligible. Eight hundred fifty-five children were evaluated over a 1-year period. The study included 704 girls and 151 boys. Children ranged in age from 3 weeks to 18 years old.
Standard STD testing (American Academy of Pediatrics recommendations) was defined as serum rapid plasma reagin test, examination for Trichomonas, N gonorrhoeae culture of the throat, rectum, and genitalia and C trachomatis culture of the rectum and genitalia. STD testing in this study was recommended in children with 1) a history of genital discharge or contact with the perpetrator's genitalia, 2) examination findings of genital discharge or trauma, and 3) all adolescents. HIV testing was obtained in children with risk factors for HIV infection, those with contact with a perpetrator with HIV risk factors, or if the family was concerned about HIV acquisition. A total of 423 children were tested for N gonorrhoeae, 415 for C trachomatis, 275 for syphilis, 208 for Trichomonas, and 140 for HIV. Twelve children were determined to have N gonorrhoeae infection, 11 had C trachomatis infection, and four had Trichomonas infection. Overall, the prevalence of STDs in prepubertal girls was 3.2% and 14.6% in pubertal girls. The prevalence of N gonorrhoeae in prepubertal girls with vaginal discharge was 11.1% and 0% in prepubertal girls without discharge (P < .001). C trachomatis infection was diagnosed in 0.8% of prepubertal girls compared with 7.0% of pubertal girls (P < .001). None of the children tested positive for syphilis or HIV and no males had a STD.
In our community, N gonorrhoeae testing in prepubertal girls can be limited to those with a vaginal discharge on examination unless other risk factors are present. The prevalence C trachomatis and Trichomonas in prepubertal girls is low and may be omitted from routine evaluations. All pubertal girls evaluated for sexual abuse should be tested for STDs because of the high prevalence of asymptomatic infection in this patient population.
确定遭受性虐待儿童沙眼衣原体、淋病奈瑟菌、阴道毛滴虫、梅毒及人类免疫缺陷病毒(HIV)感染的患病率,并制定本社区对这些儿童进行性传播疾病(STD)检测的选择标准。
前瞻性研究。
俄亥俄州一所大学附属医院。
所有在我院接受性虐待评估的儿童均符合条件。在1年时间里对855名儿童进行了评估。研究包括704名女孩和151名男孩。儿童年龄从3周龄至18岁。
标准STD检测(美国儿科学会推荐)定义为血清快速血浆反应素试验、阴道毛滴虫检查、咽喉、直肠及生殖器的淋病奈瑟菌培养以及直肠和生殖器的沙眼衣原体培养。本研究建议对以下儿童进行STD检测:1)有生殖器分泌物或与犯罪者生殖器接触史;2)生殖器分泌物或创伤的检查结果;3)所有青少年。对有HIV感染危险因素、与有HIV危险因素的犯罪者接触或其家庭担心感染HIV的儿童进行HIV检测。共有423名儿童接受淋病奈瑟菌检测,415名接受沙眼衣原体检测,275名接受梅毒检测,208名接受阴道毛滴虫检测,140名接受HIV检测。12名儿童被确定感染淋病奈瑟菌,11名感染沙眼衣原体,4名感染阴道毛滴虫。总体而言,青春期前女孩的STD患病率为3.2%,青春期女孩为14.6%。有阴道分泌物的青春期前女孩中淋病奈瑟菌患病率为11.1%,无分泌物的青春期前女孩中为0%(P<0.001)。青春期前女孩中沙眼衣原体感染率为0.8%,青春期女孩为7.0%(P<0.001)。所有儿童梅毒或HIV检测均为阴性,且无男性患有STD。
在本社区,青春期前女孩淋病奈瑟菌检测可限于检查时有阴道分泌物的儿童,除非存在其他危险因素。青春期前女孩沙眼衣原体和阴道毛滴虫患病率较低,可在常规评估中省略。由于该患者群体无症状感染患病率高,所有接受性虐待评估的青春期女孩均应进行STD检测。